Cell Source, Inc.
corporate_fare Company Profile
Cell Source, Inc. (OTC:CLCS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 2 items for CLCS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-05-14, rated 9/10. Across its 2 most recent items scored 7 or higher, the top rating is 9/10, with 2 rated 8 or above. Recent SEC coverage for CLCS spans 10-Q, 10-K.
Recent high-impact activity:
- Cell Source Reports Severe Going Concern Warning, Critically Low Cash, and Extensive Past-Due Debt
- Going Concern Warning Issued Amidst Highly Dilutive Financing Rounds to Fund Operations
Financial Snapshot
Short Interest & Short Volume
1.13 days to coverFINRA reported short interest of 1,017 shares in CLCS as of the October 30, 2026 settlement, a 32.0% decrease from the prior period — about 1.1 days to cover at its recent average daily volume. On November 16, 2026, 15.7% of CLCS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.